Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
2123 |
|
| Actual shortage: | 50 (2%) | |
| Anticipated shortage: | 9 (0%) | |
| Avoided shortage: | 19 (1%) | |
| Resolved: | 2045 (96%) | |
Discontinuation Reports |
101 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 98 (97%) | |
| Reversed: | 2 (2%) | |
Late reports |
444 (20%) |
|
Overdue reports |
38 (63%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PHENOBARBITAL SODIUM INJECTION, USP | 30MG | SOLUTION | Resolved | 2024-01-08 | 2024-04-04 | 215343 |
| PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD | 5MG | SOLUTION | Resolved | 2023-02-14 | 2023-03-02 | 184636 |
| PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD | 5MG | SOLUTION | Resolved | 2019-05-07 | 2019-10-15 | 83325 |
| PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD | 5MG | SOLUTION | Resolved | 2020-03-30 | 2020-09-08 | 110118 |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10MG | LIQUID | Resolved | 2023-06-12 | 2023-06-20 | 194769 |
| PHENYTOIN SODIUM INJECTION USP | 50MG | LIQUID | Resolved | 2022-11-16 | 2023-03-07 | 174982 |
| PHENYTOIN SODIUM INJECTION USP | 50MG | LIQUID | Resolved | 2023-03-06 | 2023-03-28 | 186267 |
| POTASSIUM PHOSPHATE MONOBASIC INJECTION | 176MG | LIQUID | Resolved | 2022-12-15 | 2023-04-07 | 178565 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 1.5G 12G | POWDER FOR SOLUTION | Resolved | 2022-11-28 | 2022-12-28 | 175996 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Resolved | 2022-11-28 | 2023-05-25 | 176000 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.25G 2G | POWDER FOR SOLUTION | Resolved | 2023-01-19 | 2023-03-21 | 181707 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Resolved | 2023-01-19 | 2023-03-14 | 181710 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 1.5G 12G | POWDER FOR SOLUTION | Resolved | 2025-02-10 | 2025-02-25 | 249983 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Resolved | 2025-02-10 | 2025-02-25 | 249989 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 1.5G 12G | POWDER FOR SOLUTION | Resolved | 2022-08-18 | 2022-09-22 | 167320 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Resolved | 2023-10-23 | 2023-11-21 | 207770 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Resolved | 2024-07-08 | 2024-09-09 | 232477 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Resolved | 2024-07-15 | 2024-08-06 | 232909 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Resolved | 2024-10-07 | 2024-12-24 | 239593 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Resolved | 2024-10-21 | 2024-11-11 | 240813 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ZOFRAN ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-03-14 | 2023-03-14 | 187062 |